No apparent correlation between levels of Sty1 binding in cells prior to and after H2O2 treatment was found (see Figure S5 in File S1).
The weakened interaction between the two domains in Y279C results in an increased level of binding between the N-SH2 domain and its pTyr ligands.
The present study indicates that PrPC might contribute to enhanced binding of α-Syn fibrils to the plasma membrane, in line with other studies reporting an increased level of binding between Aβ and PrPC during aging in several mouse models of Alzheimer's disease.
These results suggest that the salt type used can cause a dramatic difference in the level of binding between two proteins.
There was no significant difference in the level of binding between tumours arising from different sites in the colon and binding was not related to age or sex of the patient.
To quantify the level of binding between cells, we counted the percentage of Ft cells in the population adhering to Ds cells and compared these data with and without CuSO4 (±Fj expression).
In this part of the study, we set out to probe whether this genetic subtype of the disease is also a consequence of a reduced level of binding between hTR and dyskerin, as we had found in the X-linked form of the disease.
Hence, ϕ can be defined as: with where denotes probability, P polymerase, i denotes each state, μ each of the bound DNA sites comprising that state, [ X μ] the concentration of the species bound at site μ, K μ the binding affinity of that interaction, and c μ, υ the level of binding cooperativity between two occupied sites μ and υ.
This loss of binding sites is considerably faster at 37 C than at 4 C. On the other hand, once binding equilibrium is reached between nuclear bound and free triiodothyronine the level of binding does not change during the time in which a considerable loss of binding had occurred when nuclei were preincubated in the absence of hormone.
Two important factors that can be used to characterise a negative feedback loop are the feedback strength and level of binding cooperativity (nonlinearity) between an inhibitor and its regulated molecule [ 25, 26].
